HomeTERN • NASDAQ
add
Terns Pharmaceuticals Inc
Previous close
$8.14
Day range
$7.47 - $8.77
Year range
$1.87 - $9.03
Market cap
656.33M USD
Avg Volume
1.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.38M | 7.23% |
Net income | -24.09M | -5.97% |
Net profit margin | — | — |
Earnings per share | -0.26 | 16.13% |
EBITDA | -27.37M | -7.56% |
Effective tax rate | -0.27% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 315.44M | 40.01% |
Total assets | 320.42M | 38.78% |
Total liabilities | 15.19M | 24.49% |
Total equity | 305.23M | — |
Shares outstanding | 87.51M | — |
Price to book | 2.33 | — |
Return on assets | -20.75% | — |
Return on capital | -21.61% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -24.09M | -5.97% |
Cash from operations | -18.88M | -16.69% |
Cash from investing | 25.50M | -39.56% |
Cash from financing | 324.00K | -18.80% |
Net change in cash | 6.94M | -73.70% |
Free cash flow | -12.04M | -38.22% |
About
Founded
2016
Headquarters
Website
Employees
59
